{"product_id":"mod-grf-1-29-research-peptide","title":"MOD GRF 1-29  - Research Grade Peptide","description":"\u003ch3 id=\"mod-grf-1-29-research-grade-synthetic-peptide\"\u003e\n  \u003cstrong\u003e\n    MOD GRF 1-29\n    \u003cspan style=\"font-size: 12pt; line-height: 115%; font-family: Arial, sans-serif;\"\u003e\n      – Research-Grade Synthetic Peptide\n    \u003c\/span\u003e\n  \u003c\/strong\u003e\n\u003c\/h3\u003e\n\n \u003cp style=\"margin: 0 0 20px; padding: 16px 18px; color: #c00000; background-color: #fff5f5; border: 1px solid #f0c7c7; border-left: 4px solid #c00000; font-size: 14px; line-height: 1.65;\"\u003e\n    \u003cstrong\u003eFor research purposes only.\u003c\/strong\u003e\n    This product is supplied exclusively for scientific laboratory research and analytical\n    purposes. It is not intended for human or animal use, consumption, clinical use or\n    therapeutic application. It must not be used in any way that contravenes applicable\n    laws or the requirements of the Medicines and Healthcare products Regulatory Agency.\n  \u003c\/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n    \u003cstrong\u003e\n      \u003cspan style=\"color: #000000;\"\u003e\n        Research-grade synthetic 29-residue peptide with batch documentation available where supplied\n      \u003c\/span\u003e\n    \u003c\/strong\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003e\n      \u003cspan style=\"color: #000000;\"\u003e\n        Defined MOD GRF 1-29 sequence containing four specified amino-acid substitutions\n      \u003c\/span\u003e\n    \u003c\/strong\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003e\n      \u003cspan style=\"color: #000000;\"\u003e\n        C-terminally amidated structure without the additional C-terminal DAC-associated modification\n      \u003c\/span\u003e\n    \u003c\/strong\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003e\n      \u003cspan style=\"color: #000000;\"\u003e\n        Supplied as lyophilised laboratory material in sealed flip-top headspace vials\n      \u003c\/span\u003e\n    \u003c\/strong\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003e\n      \u003cspan style=\"color: #000000;\"\u003e\n        Batch identity, chromatographic purity, peptide content and analytical specifications stated in the applicable Certificate of Analysis\n      \u003c\/span\u003e\n    \u003c\/strong\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003e\n      \u003cspan style=\"color: #000000;\"\u003e\n        Handled and supplied exclusively as a research-use laboratory material\n      \u003c\/span\u003e\n    \u003c\/strong\u003e\n  \u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\n  \u003cspan style=\"color: #000000;\"\u003e\n    All of our research peptides and related laboratory materials are supplied strictly for scientific research and laboratory use only. Each vial contains lyophilised material prepared to support controlled laboratory handling and storage. The stated nominal amount refers to the declared MOD GRF 1-29 peptide content of a single vial, subject to the applicable batch documentation. Where dissolution or reconstitution is required, the solvent, buffer, concentration, handling procedure and storage conditions stated in the applicable Certificate of Analysis, Safety Data Sheet or validated laboratory method should be followed. We do not provide advice or recommendations concerning dosage, administration or use in humans or animals.\n  \u003c\/span\u003e\n\u003c\/p\u003e\n\n\u003ch3 id=\"mod-grf-1-29-chemical-and-structural-information\"\u003e\n  \u003cstrong\u003eChemical and Structural Information:\u003c\/strong\u003e\n\u003c\/h3\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n    \u003cstrong\u003eProduct Name:\u003c\/strong\u003e\n    MOD GRF 1-29\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003ePreferred Technical Description:\u003c\/strong\u003e\n    Modified GRF (1–29)\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eAlternative Names:\u003c\/strong\u003e\n    MOD GRF 1-29; Modified GRF 1–29; Modified Growth Hormone-Releasing Factor 1–29; CJC-1295 Without DAC; CJC-1295 No DAC; tetrasubstituted GRF 1–29\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eMaterial Classification:\u003c\/strong\u003e\n    Synthetic linear 29-residue peptide\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eSequence Length:\u003c\/strong\u003e\n    29 amino-acid residues\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003ePeptide Sequence:\u003c\/strong\u003e\n    H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH\u003csub\u003e2\u003c\/sub\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eSequence Shorthand:\u003c\/strong\u003e\n    Y-[D-Ala]-DAIFTQSYRKVLAQLSARKLLQDILSR-NH\u003csub\u003e2\u003c\/sub\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eSequence Modifications:\u003c\/strong\u003e\n    D-alanine at position 2, glutamine at position 8, alanine at position 15 and leucine at position 27\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eN-Terminal Structure:\u003c\/strong\u003e\n    Free tyrosine amino terminus\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eC-Terminal Structure:\u003c\/strong\u003e\n    C-terminal argininamide\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eDAC Status:\u003c\/strong\u003e\n    Does not contain the additional C-terminal maleimidopropionyl-lysine modification associated with the separate DAC-containing molecular structure\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eCommonly Assigned CAS Number:\u003c\/strong\u003e\n    863288-34-0\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003ePubChem Compound Identifier:\u003c\/strong\u003e\n    CID 56841945\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e\n    C\u003csub\u003e152\u003c\/sub\u003eH\u003csub\u003e252\u003c\/sub\u003eN\u003csub\u003e44\u003c\/sub\u003eO\u003csub\u003e42\u003c\/sub\u003e\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eAverage Molecular Weight:\u003c\/strong\u003e\n    Approximately 3367.95 g\/mol\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eElemental-Composition Note:\u003c\/strong\u003e\n    The MOD GRF 1-29 sequence contains no cysteine or methionine residue and its reference molecular formula therefore contains no sulphur\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eFormula Basis:\u003c\/strong\u003e\n    The molecular formula and molecular weight describe the uncountered, C-terminally amidated MOD GRF 1-29 molecular structure without acetate, trifluoroacetate, residual water, formulation excipients or other batch-dependent components\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003ePhysical Form:\u003c\/strong\u003e\n    Lyophilised laboratory material, as stated in the applicable batch Certificate of Analysis\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eAppearance:\u003c\/strong\u003e\n    White to off-white laboratory material, subject to confirmation in the applicable batch Certificate of Analysis\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003ePurity Specification:\u003c\/strong\u003e\n    The applicable chromatographic purity result, analytical method and acceptance criterion are stated in the batch Certificate of Analysis\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003ePeptide-Content Specification:\u003c\/strong\u003e\n    Net MOD GRF 1-29 peptide content should be distinguished from chromatographic purity and interpreted alongside water, counter-ion, residual-solvent and formulation results\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eSequence Confirmation:\u003c\/strong\u003e\n    The complete 29-residue sequence and four specified substitutions should be confirmed using the applicable synthesis and batch records\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eStereochemical Confirmation:\u003c\/strong\u003e\n    The D-alanine residue at position 2 should be supported by suitable synthesis records or stereochemical analytical documentation\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eTerminal-Structure Confirmation:\u003c\/strong\u003e\n    Molecular-identity documentation should confirm the C-terminal argininamide structure\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eMass-Spectrometry Confirmation:\u003c\/strong\u003e\n    Molecular identity should be supported by analytical mass data consistent with the specified approximately 3367.95 Da MOD GRF 1-29 structure\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eChemical-Form Confirmation:\u003c\/strong\u003e\n    The applicable Certificate of Analysis should identify whether the supplied laboratory material is the uncountered peptide, an acetate form, a trifluoroacetate form or another counter-ion form\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eCounter-Ion Confirmation:\u003c\/strong\u003e\n    Acetate, trifluoroacetate or another counter-ion may affect the total measured material mass, water content and net peptide content of the supplied laboratory material\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eResidual-Solvent Specification:\u003c\/strong\u003e\n    Applicable residual solvents arising from peptide synthesis, cleavage and chromatographic purification should be stated or controlled through the batch specification\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eRelated-Impurity Control:\u003c\/strong\u003e\n    Deletion sequences, incompletely deprotected material, stereochemical impurities, oxidation products and other synthesis-related or process-related impurities are separate quality attributes\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eEndotoxin Specification:\u003c\/strong\u003e\n    The applicable bacterial endotoxin or LPS result, analytical method, reporting units, method-suitability controls and acceptance criterion should be stated in the batch Certificate of Analysis\n  \u003c\/li\u003e\n\n  \u003cli\u003e\n    \u003cstrong\u003eAnalytical Interpretation:\u003c\/strong\u003e\n    Molecular identity, amino-acid sequence, stereochemistry, terminal structure, chromatographic purity, net peptide content, water content, residual solvents, counter-ion content and bacterial endotoxin results are separate analytical measurements and should be interpreted together\n  \u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c!-- ULTIMATE PREMIUM PRODUCT SECTION --\u003e\n\u003csection aria-labelledby=\"ultimate-mod-grf-1-29-heading\" style=\"\n    box-sizing: border-box;\n    width: 100%;\n    margin: 32px 0;\n    font-family: Arial, Helvetica, sans-serif;\n  \"\u003e\n  \u003cdiv style=\"\n      position: relative;\n      overflow: hidden;\n      box-sizing: border-box;\n      width: 100%;\n      padding: 36px;\n      background:\n        linear-gradient(\n          135deg,\n          #020202 0%,\n          #090909 25%,\n          #1c1c1c 56%,\n          #101010 77%,\n          #030303 100%\n        );\n      border: 1px solid #d4af37;\n      border-radius: 17px;\n      box-shadow:\n        0 20px 48px rgba(0, 0, 0, 0.36),\n        0 0 0 1px rgba(212, 175, 55, 0.08),\n        inset 0 1px 0 rgba(255, 239, 170, 0.08),\n        inset 0 0 32px rgba(212, 175, 55, 0.035);\n    \"\u003e\n    \u003c!-- Decorative upper gold glow --\u003e\n    \u003cdiv aria-hidden=\"true\" style=\"\n        position: absolute;\n        top: -135px;\n        right: -105px;\n        width: 360px;\n        height: 360px;\n        border-radius: 50%;\n        background:\n          radial-gradient(\n            circle,\n            rgba(255, 230, 139, 0.25) 0%,\n            rgba(212, 175, 55, 0.12) 30%,\n            rgba(212, 175, 55, 0.03) 52%,\n            rgba(212, 175, 55, 0) 73%\n          );\n      \"\u003e\u003c\/div\u003e\n\n    \u003c!-- Decorative lower gold glow --\u003e\n    \u003cdiv aria-hidden=\"true\" style=\"\n        position: absolute;\n        bottom: -170px;\n        left: -125px;\n        width: 350px;\n        height: 350px;\n        border-radius: 50%;\n        background:\n          radial-gradient(\n            circle,\n            rgba(212, 175, 55, 0.15) 0%,\n            rgba(212, 175, 55, 0.05) 40%,\n            rgba(212, 175, 55, 0) 73%\n          );\n      \"\u003e\u003c\/div\u003e\n\n    \u003c!-- Decorative premium gold top edge --\u003e\n    \u003cdiv aria-hidden=\"true\" style=\"\n        position: absolute;\n        top: 0;\n        left: 7%;\n        width: 86%;\n        height: 2px;\n        background:\n          linear-gradient(\n            90deg,\n            rgba(212, 175, 55, 0) 0%,\n            rgba(247, 223, 136, 0.80) 24%,\n            rgba(255, 238, 169, 1) 50%,\n            rgba(247, 223, 136, 0.80) 76%,\n            rgba(212, 175, 55, 0) 100%\n          );\n      \"\u003e\u003c\/div\u003e\n\n    \u003cdiv style=\"position: relative; z-index: 1;\"\u003e\n      \u003cdiv style=\"\n          display: inline-block;\n          margin: 0 0 18px;\n          padding: 8px 15px;\n          color: #f7df88;\n          background:\n            linear-gradient(\n              135deg,\n              rgba(212, 175, 55, 0.14),\n              rgba(212, 175, 55, 0.045)\n            );\n          border: 1px solid rgba(247, 223, 136, 0.72);\n          border-radius: 999px;\n          box-shadow:\n            0 5px 15px rgba(0, 0, 0, 0.22),\n            inset 0 1px 0 rgba(255, 255, 255, 0.06);\n          font-size: 11px;\n          font-weight: 700;\n          line-height: 1.2;\n          letter-spacing: 1.8px;\n          text-transform: uppercase;\n        \"\u003e\n        Premium ULTIMATE Laboratory Specification\n      \u003c\/div\u003e\n\n      \u003ch2 id=\"ultimate-mod-grf-1-29-heading\" style=\"\n          margin: 0;\n          color: #ffffff;\n          font-size: 30px;\n          font-weight: 700;\n          line-height: 1.2;\n          letter-spacing: 0.3px;\n        \"\u003e\n        \u003cspan style=\"\n            color: #f4d978;\n            text-shadow:\n              0 0 18px rgba(212, 175, 55, 0.23),\n              0 1px 0 rgba(255, 255, 255, 0.09);\n          \"\u003e\n          ULTIMATE\n        \u003c\/span\u003e\n\n        MOD GRF 1-29\n      \u003c\/h2\u003e\n\n      \u003cp style=\"\n          margin: 8px 0 0;\n          color: #f0d77d;\n          font-size: 13px;\n          font-weight: 700;\n          line-height: 1.5;\n          letter-spacing: 0.9px;\n          text-transform: uppercase;\n        \"\u003e\n        Enhanced HPLC Purification and More Stringent LPS Testing\n      \u003c\/p\u003e\n\n      \u003cp style=\"\n          margin: 11px 0 0;\n          color: #d8d8d8;\n          font-size: 15px;\n          line-height: 1.68;\n          letter-spacing: 0.15px;\n        \"\u003e\n        Additional preparative high-performance liquid chromatography purification and a more stringent bacterial endotoxin and lipopolysaccharide testing specification for demanding scientific laboratory workflows.\n      \u003c\/p\u003e\n\n      \u003cdiv aria-hidden=\"true\" style=\"\n          width: 100%;\n          height: 1px;\n          margin: 25px 0;\n          background:\n            linear-gradient(\n              90deg,\n              rgba(212, 175, 55, 0) 0%,\n              rgba(212, 175, 55, 0.72) 16%,\n              rgba(247, 223, 136, 1) 50%,\n              rgba(212, 175, 55, 0.72) 84%,\n              rgba(212, 175, 55, 0) 100%\n            );\n        \"\u003e\u003c\/div\u003e\n\n      \u003cp style=\"\n          margin: 0;\n          color: #f1f1f1;\n          font-size: 15px;\n          line-height: 1.8;\n        \"\u003e\n        The\n        \u003cstrong style=\"color: #f7df88;\"\u003e\n          ULTIMATE MOD GRF 1-29 range\n        \u003c\/strong\u003e\n        is our premium research specification for laboratories requiring an enhanced level of peptide purification and quality control. Following the standard synthesis and purification process, the finished MOD GRF 1-29 research material undergoes an additional preparative high-performance liquid chromatography purification stage designed to reduce residual peptide-related, deletion-sequence, synthesis-related and process-related impurities further. ULTIMATE batches are also assessed under a more stringent bacterial endotoxin and lipopolysaccharide testing specification, with the applicable analytical and batch documentation provided where supplied.\n      \u003c\/p\u003e\n\n      \u003cdiv style=\"\n          display: flex;\n          flex-wrap: wrap;\n          gap: 14px;\n          width: 100%;\n          margin: 27px 0;\n        \"\u003e\n        \u003c!-- ADDITIONAL HPLC PURIFICATION CARD --\u003e\n        \u003cdiv style=\"\n            box-sizing: border-box;\n            flex: 1 1 200px;\n            min-width: 0;\n            padding: 20px;\n            background:\n              linear-gradient(\n                145deg,\n                rgba(35, 35, 35, 0.97),\n                rgba(8, 8, 8, 0.99)\n              );\n            border: 1px solid rgba(212, 175, 55, 0.44);\n            border-radius: 11px;\n            box-shadow:\n              0 9px 22px rgba(0, 0, 0, 0.24),\n              inset 0 1px 0 rgba(255, 255, 255, 0.03);\n          \"\u003e\n          \u003cdiv aria-hidden=\"true\" style=\"\n              width: 34px;\n              height: 3px;\n              margin: 0 0 13px;\n              background:\n                linear-gradient(\n                  90deg,\n                  #b8860b,\n                  #f7df88,\n                  #d4af37\n                );\n              border-radius: 3px;\n            \"\u003e\u003c\/div\u003e\n\n          \u003cdiv style=\"\n              margin-bottom: 8px;\n              color: #d4af37;\n              font-size: 12px;\n              font-weight: 700;\n              line-height: 1.4;\n              letter-spacing: 1px;\n              text-transform: uppercase;\n            \"\u003e\n            Additional HPLC Purification\n          \u003c\/div\u003e\n\n          \u003cdiv style=\"\n              color: #dddddd;\n              font-size: 13px;\n              line-height: 1.62;\n            \"\u003e\n            A further preparative high-performance liquid chromatography purification stage is completed after the standard peptide purification workflow.\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003c!-- ENHANCED ENDOTOXIN AND LPS TESTING CARD --\u003e\n        \u003cdiv style=\"\n            box-sizing: border-box;\n            flex: 1 1 200px;\n            min-width: 0;\n            padding: 20px;\n            background:\n              linear-gradient(\n                145deg,\n                rgba(35, 35, 35, 0.97),\n                rgba(8, 8, 8, 0.99)\n              );\n            border: 1px solid rgba(212, 175, 55, 0.44);\n            border-radius: 11px;\n            box-shadow:\n              0 9px 22px rgba(0, 0, 0, 0.24),\n              inset 0 1px 0 rgba(255, 255, 255, 0.03);\n          \"\u003e\n          \u003cdiv aria-hidden=\"true\" style=\"\n              width: 34px;\n              height: 3px;\n              margin: 0 0 13px;\n              background:\n                linear-gradient(\n                  90deg,\n                  #b8860b,\n                  #f7df88,\n                  #d4af37\n                );\n              border-radius: 3px;\n            \"\u003e\u003c\/div\u003e\n\n          \u003cdiv style=\"\n              margin-bottom: 8px;\n              color: #d4af37;\n              font-size: 12px;\n              font-weight: 700;\n              line-height: 1.4;\n              letter-spacing: 1px;\n              text-transform: uppercase;\n            \"\u003e\n            More Stringent LPS Testing\n          \u003c\/div\u003e\n\n          \u003cdiv style=\"\n              color: #dddddd;\n              font-size: 13px;\n              line-height: 1.62;\n            \"\u003e\n            Assessed under the enhanced ULTIMATE bacterial endotoxin and lipopolysaccharide testing specification using the applicable batch-specific analytical method.\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n\n        \u003c!-- PREMIUM BATCH SPECIFICATION CARD --\u003e\n        \u003cdiv style=\"\n            box-sizing: border-box;\n            flex: 1 1 200px;\n            min-width: 0;\n            padding: 20px;\n            background:\n              linear-gradient(\n                145deg,\n                rgba(35, 35, 35, 0.97),\n                rgba(8, 8, 8, 0.99)\n              );\n            border: 1px solid rgba(212, 175, 55, 0.44);\n            border-radius: 11px;\n            box-shadow:\n              0 9px 22px rgba(0, 0, 0, 0.24),\n              inset 0 1px 0 rgba(255, 255, 255, 0.03);\n          \"\u003e\n          \u003cdiv aria-hidden=\"true\" style=\"\n              width: 34px;\n              height: 3px;\n              margin: 0 0 13px;\n              background:\n                linear-gradient(\n                  90deg,\n                  #b8860b,\n                  #f7df88,\n                  #d4af37\n                );\n              border-radius: 3px;\n            \"\u003e\u003c\/div\u003e\n\n          \u003cdiv style=\"\n              margin-bottom: 8px;\n              color: #d4af37;\n              font-size: 12px;\n              font-weight: 700;\n              line-height: 1.4;\n              letter-spacing: 1px;\n              text-transform: uppercase;\n            \"\u003e\n            Premium Batch Specification\n          \u003c\/div\u003e\n\n          \u003cdiv style=\"\n              color: #dddddd;\n              font-size: 13px;\n              line-height: 1.62;\n            \"\u003e\n            Intended for laboratory projects requiring additional peptide purification, enhanced endotoxin control and supporting batch-specific analytical documentation.\n          \u003c\/div\u003e\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n\n      \u003c!-- REGULAR VERSUS ULTIMATE COMPARISON --\u003e\n      \u003cdiv style=\"\n          box-sizing: border-box;\n          padding: 19px 21px;\n          background:\n            linear-gradient(\n              90deg,\n              rgba(212, 175, 55, 0.055),\n              rgba(255, 255, 255, 0.025)\n            );\n          border-top: 1px solid rgba(255, 255, 255, 0.08);\n          border-right: 1px solid rgba(255, 255, 255, 0.08);\n          border-bottom: 1px solid rgba(255, 255, 255, 0.08);\n          border-left: 4px solid #d4af37;\n          border-radius: 8px;\n          box-shadow:\n            inset 0 0 20px rgba(255, 255, 255, 0.012),\n            0 6px 16px rgba(0, 0, 0, 0.12);\n        \"\u003e\n        \u003cdiv style=\"\n            margin-bottom: 7px;\n            color: #f7df88;\n            font-size: 14px;\n            font-weight: 700;\n            line-height: 1.4;\n            letter-spacing: 0.2px;\n          \"\u003e\n          Regular or ULTIMATE?\n        \u003c\/div\u003e\n\n        \u003cdiv style=\"\n            color: #e5e5e5;\n            font-size: 14px;\n            line-height: 1.72;\n          \"\u003e\n          For the majority of routine analytical, investigative, peptide-characterisation and general laboratory work, our\n          \u003cstrong style=\"color: #ffffff;\"\u003e\n            Regular research-grade MOD GRF 1-29 product remains highly suitable\n          \u003c\/strong\u003e\n          and provides an appropriate balance of peptide quality, batch documentation and value. The ULTIMATE option is intended for scientific projects where the additional preparative high-performance liquid chromatography purification stage and more stringent bacterial endotoxin and lipopolysaccharide testing specification are specifically required.\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n\n      \u003cp style=\"\n          margin: 20px 0 0;\n          color: #aaaaaa;\n          font-size: 11px;\n          line-height: 1.62;\n          letter-spacing: 0.2px;\n        \"\u003e\n        ULTIMATE MOD GRF 1-29 remains strictly for scientific laboratory research and analytical use only. It is not intended for human or animal use, clinical use, diagnostic use or therapeutic application. Identity, amino-acid sequence, stereochemistry, terminal structure, chromatographic purity, peptide content, molecular form, counter-ion content, bacterial endotoxin results and other analytical specifications are batch-specific and should be confirmed using the applicable Certificate of Analysis. Bacterial endotoxin or LPS testing does not constitute sterility testing.\n      \u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/section\u003e\n\u003c!-- END ULTIMATE PREMIUM PRODUCT SECTION --\u003e\n\n\u003cp\u003e\n  \u003cspan style=\"color: #000000;\"\u003e\n    ✓ Batch documentation – Completed Certificate of Analysis documentation is provided where supplied for review.\n    \u003cbr\u003e\n\n    ✓ Certificate of Analysis – Accessible through the product QR code where provided for the applicable batch.\n    \u003cbr\u003e\n\n    ✓ Safety Data Sheet – Supplied to support appropriate laboratory handling, storage and regulatory compliance.\n    \u003cbr\u003e\n\n    ✓ Sequence documentation – The complete 29-residue amino-acid sequence and four specified substitutions should be confirmed using the applicable batch records.\n    \u003cbr\u003e\n\n    ✓ Stereochemical documentation – The D-alanine residue should be supported by appropriate synthesis or analytical documentation.\n    \u003cbr\u003e\n\n    ✓ Terminal-structure documentation – The C-terminal argininamide structure should be confirmed using the applicable molecular-identity records.\n    \u003cbr\u003e\n\n    ✓ Mass-spectrometry documentation – Molecular identity should be supported by analytical mass data consistent with the specified MOD GRF 1-29 structure.\n    \u003cbr\u003e\n\n    ✓ Purity documentation – The reported chromatographic purity applies only to the analytical method and batch stated in the Certificate of Analysis.\n    \u003cbr\u003e\n\n    ✓ Peptide-content documentation – Net MOD GRF 1-29 peptide content should be distinguished from chromatographic purity and interpreted alongside water, counter-ion and residual-solvent results.\n    \u003cbr\u003e\n\n    ✓ Chemical-form documentation – The uncountered peptide, acetate form, trifluoroacetate form or other counter-ion form should be identified clearly in the applicable product and batch records.\n    \u003cbr\u003e\n\n    ✓ Bacterial endotoxin documentation – The applicable bacterial endotoxin or LPS result should identify the test method, reporting units, method-suitability controls and acceptance criterion.\n    \u003cbr\u003e\n\n    ✓ Supplier documentation – Reviewed where supporting synthesis, purification and analytical records are supplied.\n    \u003cbr\u003e\n\n    ✓ Fast, reliable and trackable express delivery – Securely packaged and dispatched using insulated or temperature-managed packaging where required by the applicable transport and storage specification.\n  \u003c\/span\u003e\n\u003c\/p\u003e\n\n\u003cdiv style=\"text-align: center;\"\u003e\n  \u003chr style=\"width: 100%; border: 0; border-top: 1px solid #cccccc;\"\u003e\n\u003c\/div\u003e\n\n\u003cp\u003e\n  \u003cstrong\u003e\n    \u003cspan style=\"color: #c00000;\"\u003e\n      For Research Use Only\n    \u003c\/span\u003e\n  \u003c\/strong\u003e\n\n  \u003cspan style=\"color: #c00000;\"\u003e\n    \u003cbr\u003e\n    This product is supplied strictly for scientific research, laboratory analysis and experimental work. It is not intended for human consumption, animal use, clinical use, diagnostic use or any form of therapeutic application.\n  \u003c\/span\u003e\n\u003c\/p\u003e\n\n\u003cdiv style=\"text-align: center;\"\u003e\n  \u003chr style=\"width: 100%; border: 0; border-top: 1px solid #cccccc;\"\u003e\n\u003c\/div\u003e\n\n\u003ch3 id=\"mod-grf-1-29-product-overview\"\u003e\n  \u003cstrong\u003eMOD GRF 1-29 Product Overview\u003c\/strong\u003e\n\u003c\/h3\u003e\n\n\u003cp\u003e\n  \u003cspan style=\"color: #000000;\"\u003e\n    Our\n    \u003cstrong\u003eMOD GRF 1-29 research-grade synthetic peptide\u003c\/strong\u003e\n    is supplied for controlled scientific laboratory investigation, analytical method development, peptide characterisation, high-performance liquid chromatography assessment, mass-spectrometry workflows and reference-material comparison. The material comprises a defined linear sequence of 29 amino-acid residues containing four specified sequence modifications and a C-terminal amide.\n  \u003c\/span\u003e\n\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cspan style=\"color: #000000;\"\u003e\n    The reference sequence incorporates D-alanine at position 2, glutamine at position 8, alanine at position 15 and leucine at position 27. The material does not contain the additional C-terminal maleimidopropionyl-lysine modification associated with the separate DAC-containing molecular structure.\n  \u003c\/span\u003e\n\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cspan style=\"color: #000000;\"\u003e\n    The material is handled with a focus on batch traceability, documented quality control and consistent laboratory presentation. Product identity, amino-acid sequence, stereochemical configuration, terminal structure, chromatographic purity, net peptide content, molecular form, counter-ion content, water content, residual solvents, bacterial endotoxin results and other analytical specifications should be confirmed using the applicable batch Certificate of Analysis.\n  \u003c\/span\u003e\n\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cspan style=\"color: #000000;\"\u003e\n    The molecular formula C\u003csub\u003e152\u003c\/sub\u003eH\u003csub\u003e252\u003c\/sub\u003eN\u003csub\u003e44\u003c\/sub\u003eO\u003csub\u003e42\u003c\/sub\u003e and average molecular weight of approximately 3367.95 g\/mol describe the uncountered, C-terminally amidated MOD GRF 1-29 molecular structure. Where the supplied laboratory material contains acetate, trifluoroacetate or another counter-ion, the applicable batch documentation should identify the counter-ion content and whether the stated vial quantity is expressed as net peptide equivalent or total supplied material.\n  \u003c\/span\u003e\n\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cspan style=\"color: #000000;\"\u003e\n    Chromatographic purity should not automatically be interpreted as equivalent to total net peptide content. Likewise, a bacterial endotoxin or LPS result does not establish sterility, molecular identity, correct stereochemistry, sequence integrity, terminal amidation or the absence of every synthesis-related and process-related impurity.\n  \u003c\/span\u003e\n\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cspan style=\"color: #000000;\"\u003e\n    For the majority of routine analytical, investigative, peptide-characterisation and general laboratory work, the Regular MOD GRF 1-29 specification remains highly suitable. The premium black-and-gold ULTIMATE MOD GRF 1-29 option provides an additional preparative high-performance liquid chromatography purification stage and a more stringent bacterial endotoxin and lipopolysaccharide testing specification for scientific projects requiring enhanced quality-control parameters.\n  \u003c\/span\u003e\n\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003ca href=\"https:\/\/researchscientific.co.uk\/coa\/PEP086.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\n    View Certificate of Analysis\n  \u003c\/a\u003e\n\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003ca href=\"https:\/\/researchscientific.co.uk\/msds\/PEP086.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\n    View Safety Data Sheet\n  \u003c\/a\u003e\n\u003c\/p\u003e","brand":"Research Scientific","offers":[{"title":"2mg","offer_id":50256486793554,"sku":"PEP086\/2mg","price":15.66,"currency_code":"GBP","in_stock":false},{"title":"5mg","offer_id":50256486826322,"sku":"PEP086\/5mg","price":36.72,"currency_code":"GBP","in_stock":true},{"title":"10mg","offer_id":50256486859090,"sku":"PEP086\/10mg","price":68.54,"currency_code":"GBP","in_stock":true},{"title":"20mg","offer_id":50256486891858,"sku":"PEP086\/20mg","price":127.3,"currency_code":"GBP","in_stock":true},{"title":"50mg","offer_id":50256486924626,"sku":"PEP086\/50mg","price":293.76,"currency_code":"GBP","in_stock":true},{"title":"5 x 5mg Lab Pack 1","offer_id":51256700076370,"sku":"PEP086 \/5mg x 5 Lab Pack","price":153.0,"currency_code":"GBP","in_stock":true},{"title":"10 x 5mg Lab Pack 2","offer_id":51256702271826,"sku":"PEP086 \/5mg x 10 Lab Pack","price":306.0,"currency_code":"GBP","in_stock":true},{"title":"5 x 10mg Lab Pack 3","offer_id":51256704598354,"sku":"PEP086 \/10mg x 5 Lab Pack","price":285.58,"currency_code":"GBP","in_stock":true},{"title":"10 x 10mg Lab Pack 4","offer_id":51256706269522,"sku":"PEP086 \/10mg x 10 Lab Pack","price":571.17,"currency_code":"GBP","in_stock":true},{"title":"5mg - Ultimate","offer_id":54648326324562,"sku":"PEP086U\/5mg","price":51.41,"currency_code":"GBP","in_stock":true},{"title":"10mg - Ultimate","offer_id":54648326357330,"sku":"PEP086U\/10mg","price":95.96,"currency_code":"GBP","in_stock":true},{"title":"20mg - Ultimate","offer_id":54648326390098,"sku":"PEP086U\/20mg","price":178.22,"currency_code":"GBP","in_stock":true},{"title":"50mg - Ultimate","offer_id":54648326422866,"sku":"PEP086U\/50mg","price":411.26,"currency_code":"GBP","in_stock":true},{"title":"5 x 5mg Lab Pack 5 - Ultimate","offer_id":54648326455634,"sku":"PEP086U\/5mg x 5 Lab Pack","price":214.2,"currency_code":"GBP","in_stock":true},{"title":"10 x 5mg Lab Pack 6 - Ultimate","offer_id":54648326488402,"sku":"PEP086U\/5mg x 10 Lab Pack","price":428.4,"currency_code":"GBP","in_stock":true},{"title":"10 x 10mg Lab Pack 8 - Ultimate","offer_id":54648326521170,"sku":"PEP086U\/10mg x 5 Lab Pack","price":399.81,"currency_code":"GBP","in_stock":true},{"title":"5 x 10mg Lab Pack 7 - Ultimate","offer_id":54648326553938,"sku":"PEP086U\/10mg x 10 Lab Pack","price":799.64,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0931\/9769\/7362\/files\/nupex-mod-grf-1-29-research-peptide-pure-fine-powder.png?v=1767865758","url":"https:\/\/nupex.co.uk\/products\/mod-grf-1-29-research-peptide","provider":"Nupex","version":"1.0","type":"link"}